Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vericel Corp (NASDAQ:VCEL)

3.46
Delayed Data
As of 11:31am ET
 -0.04 / -1.14%
Today’s Change
2.55
Today|||52-Week Range
4.35
+13.82%
Year-to-Date
No recent news for Vericel Corp.

Today’s Trading

Previous close3.50
Today’s open3.49
Day’s range3.45 - 3.49
Volume6,334
Average volume (3 months)49,710
Market cap$83.3M
Dividend yield--
Data as of 11:31am ET, 08/04/2015

Growth & Valuation

Earnings growth (last year)+67.91%
Earnings growth (this year)+60.76%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+151,457.89%
P/E ratioNM
Price/Sales1.23
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NNVCNanoViricides Inc-0.04-2.78%
BLRXBioLine RX Ltd-0.02-1.29%
BOTABiota Pharmaceutical...+0.03+1.24%
AVEOAveo Pharmaceuticals...-0.02-1.38%
Data as of 12:42pm ET, 08/04/2015

Financials

Next reporting dateAugust 13, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$28.8M
Annual profit (last year)-$19.9M
Net profit margin-69.18%

Profile

Sector
Health Technology
Industry
Medical Specialties
President &
Chief Executive Officer
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts